-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ti/pTWF5FW3bQVy5YQI7Ggc+cnG6/Vo1EIjfqc06f6aV1EbT11vYOcwL8A+u8Zpz hiZung30c+lMNE/9KffOMw== 0000878088-10-000007.txt : 20100106 0000878088-10-000007.hdr.sgml : 20100106 20100106143122 ACCESSION NUMBER: 0000878088-10-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100104 FILED AS OF DATE: 20100106 DATE AS OF CHANGE: 20100106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEPORE PATRICK G CENTRAL INDEX KEY: 0001055404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 10511068 MAIL ADDRESS: STREET 1: 17-17 ROUTE 208 N CITY: FAIRLAWN STATE: NJ ZIP: 07410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-01-04 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001055404 LEPORE PATRICK G C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BLVD WOODCLIFF LAKE NJ 07677 1 1 0 0 Chairman, President & CEO Common Stock 2010-01-04 4 A 0 27066 0 A 240402 D Common Stock 15000 I By Limited Partnership Common Stock 15000 I By Trust Common Stock, Option to Buy 27.71 2010-01-04 4 A 0 54132 0 A 2020-01-04 Common Stock 54132 54132 D Award of shares of Restricted Stock under the Company's 2004 Performance Equity Plan. 25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary until fully vested. The closing price of the Company's Common Stock as reported by The New York Stock Exchange on the date of grant was $27.71. Includes (i) 59,137 shares of Common Stock, and (ii) 181,265 shares of Restricted Stock and Restricted Stock Units, held by Mr. LePore. The shares are held by Park Street Investors, L.P. ("PSI"), a Delaware limited partnership. The General Partner of PSI is Park Street Investment Corporation ("PSIC"), a Delaware corporation, of which Mr. LePore and his spouse are officers and directors and together own a majority of the outstanding stock of PSIC. The shares are held by the Patrick LePore Revocable Trust of 2002, of which Mr. LePore is the Grantor, Trustee and beneficiary. Award of Option to purchase shares of Common Stock under the Company's 2004 Performance Equity Plan. 25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary until fully vested. LIMITED POWER OF ATTORNEY: KNOW ALL MEN BY THESE PRESENTS, that the undersigned does hereby constitute and appoint MARIAN E. GUSTAFSON with full power to act, as his/her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in any and all capacities, and to do any and all acts and things in his/her name and on his/her behalf, to execute any and all documents and instruments, which said attorney-in-fact may deem necessary or advisable to enable him/her to comply with the reporting requirements pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, including but not limited to Form 4-Statement of Changes in Beneficial Ownership and Form 5-Annual Statement of Changes in Beneficial Ownership, relating to his/her ownership in Par Pharmaceutical Companies, Inc. (the "Company") for the period October 1, 2009 through and including September 30, 2010; and to file the same, and all oth er documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that the said attorney-in-fact and agent may lawfully do or cause to be done by virtue thereof. /s/ Patrick G. LePore Dated: September 14, 2009 /s/ Marian E. Gustafson for Patrick G. LePore 2010-01-06 -----END PRIVACY-ENHANCED MESSAGE-----